IRONWOOD PHARMACEUTICALS INC (IRWD) earnings date, results and what the price requires

    Nasdaq · SEC CIK 0001446847 · SEC filings checked Oct 17, 2026

    Next report
    Nov 9, 2026
    Estimated from reporting history (95-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
    Last close
    $3.50
    Polygon.io daily close, Oct 16, 2026. End of day, not live.
    Trailing diluted EPS
    $0.77
    Sum of quarters ending Jun 30, 2026, Mar 31, 2026, Dec 31, 2025, Sep 30, 2025 · P/E 4.5

    Previous results (SEC filings)

    Quarter endedReportedRevenueNet incomeDiluted EPSSource
    Jun 30, 2026Aug 6, 2026$113.0M$51.3M$0.31Filing
    Mar 31, 2026May 7, 2026$106.5M$40.8M$0.24Filing
    Dec 31, 2025Feb 25, 2026$47.7M$-2.3M$-0.01Filing
    Sep 30, 2025Nov 10, 2025$122.1M$40.1M$0.23Filing
    Jun 30, 2025Aug 7, 2025$85.2M$23.6M$0.14Filing
    Mar 31, 2025Apr 25, 2025$41.1M$-37.4M$-0.23Filing
    Dec 31, 2024Feb 27, 2025$90.5M$2.3M$0.01Filing
    Sep 30, 2024Nov 7, 2024$91.6M$3.6M$0.02Filing

    What would IRONWOOD PHARMACEUTICALS INC have to report for its valuation to change?

    At $3.50, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -17.2% a year, to $0.30. On that path the next quarter needs diluted EPS near $0.19, against $0.23 in the quarter ended Sep 30, 2025.

    Are you considering buying, or do you already own shares?

    Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.

    ResultOriginalYours
    Required EPS growth / year-17.2%-17.2%
    EPS needed in final year$0.30$0.30

    Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.

    Prepare for earnings across my investments — $399/month

    Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. IRWD goes in with your buy-or-wait comparison and assumptions preserved.

    Start Desk — $399/month

    Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.